Ticker
EBSCompany Name
EMERGENT BIOSOLUTIONS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 439.61M | $ 4M | $ -202.7M | $ 0 | 45.2% |
3/31/2025 | $ 345.21M | $ 10.9M | $ -254.1M | $ 0 | 70.45% |
12/31/2024 | $ 347.21M | $ 10.8M | $ -213M | $ 0 | 58.24% |
9/30/2024 | $ 596.03M | $ 10.7M | $ -208.9M | $ 0 | 33.25% |
6/30/2024 | $ 302.63M | $ 1.4M | $ -49.1M | $ 0 | 15.76% |
3/31/2024 | $ 172.93M | $ 10.2M | $ -493.9M | $ 0 | 279.71% |
12/31/2023 | $ 140.43M | $ 10.2M | $ -543.4M | $ 0 | 379.7% |
9/30/2023 | $ 109.99M | $ 11.3M | $ -196M | $ 0 | 167.92% |
6/30/2023 | $ 306.7M | $ 11.3M | $ 76.5M | $ 0 | -28.63% |
3/31/2023 | $ 545.34M | $ -20.1M | $ 564.3M | $ 0 | -99.79% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for EMERGENT BIOSOLUTIONS INC is calculated as follows: (-1 * CF - Equity [ $ 29.1M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 47.3M ]) / Market Cap [ $ 4.89B ]
(=) Shareholder Yield [ -1.56% ]
Minimum
Mar 31, 2023
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |